Call Vector Medical Billing
+1 (929) 539-7737
50States
Oncology Billing Services
Oncology billing runs on three ledgers the same day — the drug, the administration hierarchy, and the visit — each with its own units. Vector Medical Billing, in Jamaica, New York, codes chemotherapy and infusion from the treatment record, reconciles J-code units to the dose given, attaches JW/JZ when Medicare requires it, and runs the claim cycle inside the EHR you already use.
98%Published NCR
24hClaim Submission
BAASigned with every client
AAPCCertified coders
AHIMACertified coders
E&OErrors and omissions insured
50 StatesRemote billing nationwide
Monthly fee
What oncology billing services include
Full-cycle RCM for medical oncology, hematology-oncology, and office-based infusion — drug, chair time, and visit on one claim.
The operating cycle matches medical billing services: eligibility, charge capture from the infusion record, ICD-10 / CPT / HCPCS coding, scrub, clearinghouse submission, payment posting, denial management, and A/R follow-up. The scrub watches the administration hierarchy, J-code units against the dose, JW/JZ on single-dose vials, authorization match to the regimen, and same-day E/M when modifier 25 is supported.
In scope: community and independent oncology practices, infusion centers under buy-and-bill, and multi-drug regimens where supportive drugs sit beside chemo codes. Hospital outpatient facility technical bills on UB-04 stay out unless separately agreed. Radiation planning and delivery sit on radiation oncology billing when that is a separate account.
Oncology is priced as a percentage of net collections. Credentialing, a retrospective coding audit, MIPS, and out-of-network / IDR stay separate engagements.
What sits on this oncology fee
- Admin codes built from start/stop times — not a flat “chemo given” habit
- Drug units and wastage modifiers reconciled before submission
- HIPAA workflows, a signed BAA, and PHI limited to staff on the account
Where oncology claims fail
Patterns CMS chemo articles, JW/JZ FAQs, and specialty oncology RCM vendors keep naming.
Wrong admin hierarchy
Chemotherapy infusion is ranked: one initial IV infusion (96413) per encounter through a single IV site, then each additional hour (96415) and each sequential different drug (96417). A second “initial,” a missed sequential add-on, or push billed as infusion triggers edits or leaves chair time unpaid.
Vector codes from documented start and stop times — not from a recycled initial code on every chair.
Drug units or JW/JZ wrong
Under buy-and-bill the practice already paid for the agent. Units must follow the J-code descriptor for the dose administered — not the vial size. Single-dose Part B lines need JW (discarded) or JZ (zero waste). Missing attestation can return the claim as unprocessable.
The scrub reconciles milligrams to billing units and attaches the wastage line the record supports.
Auth vs regimen drift
Commercial and Medicare Advantage plans gate chemo and biologics behind prior auth. A dose change, drug swap, or expired approval turns a covered day into a denial after the drug is already hung.
Vector ties prior authorization to the exact drug, units, and cycle on the claim — and flags regimen changes before submission.
96413 · 96415 · 96417
Chemotherapy administration hierarchy
Infusion outranks push, which outranks injection — and only one initial service per encounter unless separate IV access is medically necessary.
CPT 96413 reports the initial intravenous infusion of up to one hour of a single or initial substance. 96415 is the add-on for each additional hour of that same infusion when time supports it. 96417 reports each additional sequential infusion of a different drug. IV push uses 96409 (initial) with sequential push add-ons as documented. Subcutaneous or intramuscular chemo uses 96401 / 96402 — not a therapeutic injection code meant for supportive drugs.
CMS NCCI Chapter XI rules most practices break: only one “initial” administration code per encounter through one IV site (two lumens of one catheter count as one site). Supportive agents — growth factors, antiemetics, saline used only to deliver drug — are not chemotherapy administration. Hydration (96360 / 96361) is billable when medically necessary before or after chemo and timed long enough; incidental fluid to keep a line open is not.
What the scrub checks on the chair
- Start/stop times support initial vs additional-hour vs sequential codes
- One initial admin code unless separate access is documented and modified
- Supportive drugs on therapeutic/hydration families — not chemo codes
Buy-and-bill drugs: units, ASP, JW/JZ
The drug cabinet is a second ledger. A denied J-code is inventory loss, not deferred revenue.
ASP + 6% payment logic
Most separately payable Part B physician-administered drugs pay at Average Sales Price plus 6%. Fee schedules update quarterly. Units come from the HCPCS descriptor (for example milligrams per unit), not from “one vial = one unit.” Wrong math either underpays the inventory cost or trips Medically Unlikely Edits.
J-code units and NDC
Bill the dose administered in the code’s billing units. Many Medicaid and commercial plans require the NDC of the product actually used (5-4-2 format). Unclassified drugs (for example J9999 / J3490 / J3590 paths when no specific code exists) need drug name, dose, and NDC in claim remarks — incomplete NOC lines are a frequent denial reason.
JW and JZ wastage
For single-dose containers: JW on a separate line for discarded amount (documented in the record); JZ on the administered line when nothing was discarded. Multi-dose vials do not take these modifiers. Vector attaches the attestation the MAR supports so Medicare Part B single-dose claims are processable.
The visit and the authorization
Drug and admin are not the whole claim — the same-day E/M and the auth file decide whether the day pays clean.
Same-day E/M (modifier 25)
Administration codes are valued to include 99211 — that level is not separately payable with chemo admin. A significant, separately identifiable office visit can be reported with modifier 25 when the note supports it. Missing 25 bundles the visit; overusing 25 invites audit.
Prior auth by regimen
Track authorizations by drug, dose, units, and cycle date — not only by patient name. Before each cycle, confirm the approval still matches what will be billed. Regimen changes that void an auth surface before the infusion, not after the denial.
Office vs hospital setting
Physicians report drug administration codes for office services. Hospital outpatient departments report facility administration on their own path; PC/TC indicator 5 incident-to codes are not paid to physicians for hospital inpatients or outpatients. Wrong setting routing looks like a coding failure but is a place-of-service failure.
Three ledgers, one treatment day
Hub language made operational: the drug, the administration, and the visit — each with its own units.
1 — The drug
HCPCS J-code (or NOC when required), billing units from the descriptor, NDC when the payer requires it, JW or JZ on single-dose Part B lines. This is buy-and-bill margin protection.
2 — The administration
Initial infusion / push / injection, additional hours, sequential drugs, and separately reportable hydration when medical necessity and time are documented. One initial rule applies.
3 — The visit
Separately identifiable E/M with modifier 25 when the physician work is above the admin-valued 99211. Diagnosis pointers must support medical necessity for drug and admin lines.
Medicare vs commercial oncology edits
Same chair, different fail modes — the scrub does not use one habit on every payer.
Medicare Part B is where JW/JZ and ASP unit math bite hardest: single-dose claims without the correct wastage attestation may be returned as unprocessable, and a units error on a high-cost biologic is a direct hit to buy-and-bill margin. Chemo administration still needs an associated drug code on the claim in most settings, and 99211 is not payable with drug administration.
Commercial and Medicare Advantage plans add pathway prior authorization, site-of-care policies, and NDC formatting rules that vary by contract. Administering before approval posts — or billing units that do not match the authorized dose — converts a covered regimen into a denial after inventory is already spent. Vector loads payer-specific auth and unit rules into the scrub instead of treating every remittance as a surprise.
Controls before the claim leaves
- JW or JZ on every applicable Part B single-dose line
- Auth drug / units / cycle matched to what will be billed
- Quarterly ASP fee-schedule refresh so drug remits are comparable
Medicare · commercial · MA
Oncology code families this service works
Illustrative anchors — the treatment record and payer policy decide the final claim.
| Work type | Example | What to check | Common failure if skipped |
|---|---|---|---|
| Chemo IV infusion | 96413 / 96415 / 96417 | Times; one initial; sequential drugs | Second initial; missed 96417 |
| Chemo IV push / SQ-IM | 96409; 96401 / 96402 | Technique vs infusion; hormonal vs non-hormonal | Push billed as infusion hour |
| Hydration / therapeutic | 96360–96361; 96365–96375 | Necessity; time ≥31 min for initial hydration | Incidental fluid billed as hydration |
| Part B drugs | J-codes / NOC (e.g. J9999) | Units vs dose; NDC; quarterly ASP | Vial-size units; missing NDC |
| Wastage | JW / JZ | Single-dose only; documented discard | No modifier → unprocessable |
| Same-day visit | E/M + 25 | Separately identifiable work | 99211 with admin; missing 25 |
This page does not invent an oncology denial percentage. The free audit reads your hierarchy misses, unit errors, and JW/JZ gaps on the sample you send.
What a free audit line looks like
Illustrative composite only — not a client result and not a promised recovery.
| Field | Example entry |
|---|---|
| Documented service | Office infusion: Drug A IV 55 min, Drug B sequential IV 40 min; single-dose vial with 20 mg discarded; separately identifiable established visit for toxicity review; auth on file for Drug A only |
| Billed codes | 96413 ×2; J-code units matching full vial; no JW; no 96417; E/M without 25; Drug B without auth check |
| Issue found | Two initials violate one-initial rule; sequential Drug B needs 96417 not a second 96413; discarded amount needs JW line; visit needs 25 if separately identifiable; Drug B auth missing |
| Recommended correction | 96413 + 96417; J-code administered units + JW discarded units; append 25 to supported E/M; obtain or hold Drug B until auth matches |
| Related check | Confirm start/stop times on MAR and NDC matches product used |
| Why it matters | Stacked hierarchy + wastage + auth errors on one high-dollar day — caught in scrub or flagged in the free audit |
Request a Free Audit with recent infusion records, claims, and denials. We map hierarchy, units, and JW/JZ on your file — not this composite.
How Vector runs oncology billing
Specialty assignment and drug/admin reconciliation first — then the same revenue cycle.
1
Assign oncology
Coder and biller who already work infusion hierarchy, J-codes, JW/JZ, and regimen auth.
2
Reconcile and code
Charge entry and coding from the MAR — queries when times or units cannot be supported.
4
Post and report
835 posting, denial work, A/R aging, monthly RCM report — including drug-line variance vs ASP.
Not inside the oncology percentage
Related work stays separate so the quote matches the job.
Credentialing
Provider credentialing for oncologists across commercial and Medicare Advantage panels is a separate project.
Coding audit
A retrospective billing and coding audit of hierarchy, units, and JW/JZ is scoped on its own when you want a period review.
Underpay / OON
Underpayment recovery and OON / IDR are separate when the dispute path is not ordinary denial work.
How oncology billing is priced
Percentage of dollars that land — not a flat fee per infusion that ignores hard drug denials.
Written rate
Oncology is priced as a percentage of net collections. No setup fee on the monthly cycle. Month to month. The written rate follows infusion volume, drug mix, payer mix, and how much of the cycle you hand over.
See pricing or request a written rate after the free audit.
What we need to start
EHR access, monthly infusion volume and top drugs, fee schedule or payer mix, open A/R if you are leaving another biller, and a sample of recent hierarchy or JW/JZ denials. Switching usually overlaps so claim submission does not stop. See EHR integration if access setup needs a separate quote.
Audit the oncology claims that are already failing
Send monthly infusion volume, top drugs and payers, EHR name, and a sample of hierarchy or drug-unit denials. We reply with what the open A/R shows, whether the monthly fee fits, and a written rate — without inventing a clean-claim percentage.
Written
Monthly rate
98%
Published NCR
50
US States
BAA
Every Client
Oncology billing questions
Straight answers tied to the sections above.
What does oncology billing include?
Chemotherapy and infusion administration coding from start/stop times, Part B drug (J-code) units and NDC, JW/JZ on single-dose vials, prior authorization tied to the regimen, same-day E/M when separately identifiable, claim scrubbing, submission, payment posting, denial management, and A/R follow-up.
How much do oncology billing services cost?
The fee is a percentage of net collections. No setup fee on the monthly cycle. The written rate follows infusion volume, drug mix, and payer mix.
How is oncology different from office visit billing?
An oncology treatment day has three ledgers: the drug, the administration hierarchy, and the visit when it is separately identifiable. Each line has its own units. Missing one is chair time or inventory loss — not a mid-level E/M problem.
What are JW and JZ modifiers?
JW reports discarded drug from a single-dose container on a separate line. JZ attests zero waste when nothing was discarded. Medicare requires them on separately payable Part B single-dose-container drugs (JZ since July 1, 2023). Claims without the correct attestation may be returned as unprocessable.
How does Medicare pay for chemotherapy drugs?
Most separately payable physician-administered Part B drugs pay at ASP + 6%. Units must match the HCPCS descriptor for the dose administered — not the vial size. Fee schedules update quarterly.
Do we have to change our EHR?
No. Billers work in the system you already use — see EHR integration. Compatibility is confirmed before you commit.
Where does Vector provide oncology billing?
The office is 15717 85th St, Jamaica, NY 11414-2620. Work is remote for oncology practices in all 50 states. See the specialties hub.
Is Vector Medical Billing HIPAA certified?
HHS does not certify billing companies. Vector signs a BAA, limits PHI to staff on the account, and follows HIPAA workflows. A HIPAA security risk analysis is a separate engagement when scoped.